These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23752890)
1. Cardiovascular disease: Is LDL-C level a good indicator of coronary risk in people with nondialysis-dependent CKD? Kelsey R Nat Rev Nephrol; 2013 Jul; 9(7):369. PubMed ID: 23752890 [No Abstract] [Full Text] [Related]
2. Association between LDL-C and risk of myocardial infarction in CKD. Tonelli M; Muntner P; Lloyd A; Manns B; Klarenbach S; Pannu N; James M; Hemmelgarn B; J Am Soc Nephrol; 2013 May; 24(6):979-86. PubMed ID: 23687359 [TBL] [Abstract][Full Text] [Related]
3. A piece of the puzzle in the cardiorenal conundrum. Lin J J Am Soc Nephrol; 2013 May; 24(6):870-2. PubMed ID: 23687358 [No Abstract] [Full Text] [Related]
4. Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease. Emanuelsson F; Nordestgaard BG; Benn M J Clin Endocrinol Metab; 2018 Dec; 103(12):4491-4500. PubMed ID: 30085243 [TBL] [Abstract][Full Text] [Related]
5. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital. Sangsawang T; Sriwijitkamol A Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial. Charytan DM; Sabatine MS; Pedersen TR; Im K; Park JG; Pineda AL; Wasserman SM; Deedwania P; Olsson AG; Sever PS; Keech AC; Giugliano RP; J Am Coll Cardiol; 2019 Jun; 73(23):2961-2970. PubMed ID: 31196453 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. Wang C; Li Y; Zhang J; Ye Z; Zhang Q; Ma X; Peng H; Lou T J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792646 [TBL] [Abstract][Full Text] [Related]
8. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials. Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855 [TBL] [Abstract][Full Text] [Related]
9. Variability in low-density lipoprotein cholesterol and cardiovascular risk: should consistency be a new target? Baber U; Halperin JL J Am Coll Cardiol; 2015 Apr; 65(15):1549-51. PubMed ID: 25881937 [No Abstract] [Full Text] [Related]
10. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH; J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936 [TBL] [Abstract][Full Text] [Related]
11. Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients. Shen H; Xu Y; Lu J; Ma C; Zhou Y; Li Q; Chen X; Zhu A; Shen G BMC Nephrol; 2016 Oct; 17(1):143. PubMed ID: 27716087 [TBL] [Abstract][Full Text] [Related]
12. [Acute coronary syndrome in patients with chronic kidney disease--risk stratification]. Babińska M; Chudek J; Owczarek AJ; Prochaczek F; Wiecek A Pol Arch Med Wewn; 2005 Dec; 114(6):1226-35. PubMed ID: 16789494 [No Abstract] [Full Text] [Related]
13. Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines. Shimizu R; Torii H; Yasuda D; Hiraoka Y; Kitada N; Hashida T; Yoshimoto A; Kita T; Kume N J Atheroscler Thromb; 2015; 22(9):949-57. PubMed ID: 25843151 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease. Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129 [TBL] [Abstract][Full Text] [Related]
16. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Mortensen MB; Nordestgaard BG Lancet; 2020 Nov; 396(10263):1644-1652. PubMed ID: 33186534 [TBL] [Abstract][Full Text] [Related]
17. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study. Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842 [TBL] [Abstract][Full Text] [Related]
18. LDL cholesterol in CKD--to treat or not to treat? Massy ZA; de Zeeuw D Kidney Int; 2013 Sep; 84(3):451-6. PubMed ID: 23698234 [TBL] [Abstract][Full Text] [Related]
19. Association between lipid fractions and age of first myocardial infarction. Bødtker H; Gunnersen S; Adelborg K; Kulenovic I; Kanstrup H; Falk E; Bruun JM; Mortensen MB Scand Cardiovasc J; 2020 Dec; 54(6):346-351. PubMed ID: 32483990 [TBL] [Abstract][Full Text] [Related]
20. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP; Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]